Health-Economic Comparison of Paricalcitol, Calcitriol and Alfacalcidol for the Treatment of Secondary Hyperparathyroidism during Haemodialysis

Author： Rosery Hubertus

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.26, Iss.11, 2006-01, pp. : 629-638

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Health-Economic Comparison of Paricalcitol, Calcitriol and Alfacalcidol for the Treatment of Secondary Hyperparathyroidism during Haemodialysis

By Fiedler Roman

Clinical Drug Investigation, Vol. 27, Iss. 12, 2007-01 ,pp. : 865-866

Adis International

Access to resources Recommend Favorite

IV paricalcitol the clear winner in secondary hyperparathyroidism

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Paricalcitol: A Review of its Use in the Management of Secondary Hyperparathyroidism

By Dean M. Robinson Lesley J. Scott

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 559-576

Adis International

Access to resources Recommend Favorite

IV paricalcitol the clear winner in secondary hyperparathyroidism

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy

By Eandi Mario

PharmacoEconomics, Vol. 28, Iss. 11, 2010-11 ,pp. : 1041-1054

Adis International

Access to resources Recommend Favorite